Literature DB >> 28840295

Liver Function, Quantified by LiMAx Test, After Major Abdominal Surgery. Comparison Between Open and Laparoscopic Approach.

Magnus Kaffarnik1, Gabriel Stoeger2, Julia Liebich2, Christian Grieser3, Johann Pratschke2, Martin Stockmann2.   

Abstract

INTRODUCTION: Major abdominal surgery may lead to a systemic inflammatory response (SIRS) with a risk of organ failure. One possible trigger for a postoperative hepatic dysfunction is an altered hepatic blood flow during SIRS, resulting in a decreased oxygen delivery. This pilot study investigated the role of liver dysfunction measured by the LiMAx test after major abdominal surgery, focussing on open and laparoscopic surgical approaches.
METHODS: We prospectively investigated 25 patients (7 females and 18 males, age range 55-72 years) scheduled for upper abdominal surgery. The LiMAx test, ICG-PDR and duplex sonography were carried out preoperatively, followed by postoperative days (PODs) 1, 3, 5 and 10. Laboratory parameters and clinical parameters were measured daily. Clinical outcome parameters were examined at the end of treatment. The population was divided into group A (laparotomy) versus group B (laparoscopy).
RESULTS: LiMAx values decreased significantly on POD 1 (290 µg/kg/h, P < 0.001), followed by a significant increase at POD 3 (348 µg/kg/h, P = 0.013). Only INR showed a significant increase on POD 1 (1.26, P < 0.001). Duplex sonography and ICG-PDR revealed a hyper-dynamic liver blood flow. No differences between group A and B were found.
CONCLUSIONS: Hepatic dysfunction after major abdominal surgery is evident and underestimated. The LiMAx test provides an adequate tool to determine liver dysfunction. Open and laparoscopic approaches appeared similar in terms of liver dysfunction and postoperative SIRS.

Entities:  

Mesh:

Year:  2018        PMID: 28840295     DOI: 10.1007/s00268-017-4170-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  31 in total

1.  The handling of indocyanine green by the liver.

Authors:  G Paumgartner
Journal:  Schweiz Med Wochenschr       Date:  1975

2.  Laparoscopically assisted transhiatal resection for malignancies of the distal esophagus.

Authors:  W T Van den Broek; O Makay; F J Berends; J Z Yuan; A P J Houdijk; S Meijer; M A Cuesta
Journal:  Surg Endosc       Date:  2004-04-06       Impact factor: 4.584

Review 3.  Assessing liver function.

Authors:  Samir G Sakka
Journal:  Curr Opin Crit Care       Date:  2007-04       Impact factor: 3.687

4.  Comparison of the outcomes between open and minimally invasive esophagectomy.

Authors:  Bernard M Smithers; David C Gotley; Ian Martin; Janine M Thomas
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

Review 5.  The immune response to surgery and trauma: Implications for treatment.

Authors:  Paul E Marik; Mark Flemmer
Journal:  J Trauma Acute Care Surg       Date:  2012-10       Impact factor: 3.313

Review 6.  Systematic review: acute liver failure - one disease, more than 40 definitions.

Authors:  K A Wlodzimirow; S Eslami; A Abu-Hanna; M Nieuwoudt; R A F M Chamuleau
Journal:  Aliment Pharmacol Ther       Date:  2012-04-16       Impact factor: 8.171

7.  Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients.

Authors:  Samir G Sakka; Konrad Reinhart; Andreas Meier-Hellmann
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

8.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; A de Mendonça; F Cantraine; R Moreno; J Takala; P M Suter; C L Sprung; F Colardyn; S Blecher
Journal:  Crit Care Med       Date:  1998-11       Impact factor: 7.598

9.  Clinical impact of interleukin 6 as a predictive biomarker in the early diagnosis of postoperative systemic inflammatory response syndrome after major thoracic surgery: A prospective clinical trial.

Authors:  Nicole Fink-Neuboeck; Joerg Lindenmann; Sedin Bajric; Alfred Maier; Regina Riedl; Annelie Martina Weinberg; Freyja Maria Smolle-Juettner
Journal:  Surgery       Date:  2016-05-17       Impact factor: 3.982

10.  Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purity.

Authors:  R Heintz; C K Svensson; K Stoeckel; G J Powers; D Lalka
Journal:  J Pharm Sci       Date:  1986-04       Impact factor: 3.534

View more
  2 in total

1.  The LiMAx Test as Selection Criteria in Minimally Invasive Liver Surgery.

Authors:  Mirhasan Rahimli; Aristotelis Perrakis; Andrew A Gumbs; Mihailo Andric; Sara Al-Madhi; Joerg Arend; Roland S Croner
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

2.  Randomized clinical trial comparing liver resection with and without perioperative assessment of liver function.

Authors:  M Stockmann; F W R Vondran; R Fahrner; H M Tautenhahn; J Mittler; H Bektas; M Malinowski; M Jara; I Klein; J F Lock
Journal:  BJS Open       Date:  2018-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.